A detailed history of Newbridge Financial Services Group, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 508 shares of MDT stock, worth $43,047. This represents 0.02% of its overall portfolio holdings.

Number of Shares
508
Previous 492 3.25%
Holding current value
$43,047
Previous $38,000 18.42%
% of portfolio
0.02%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.84 - $91.03 $1,229 - $1,456
16 Added 3.25%
508 $45,000
Q4 2023

Mar 28, 2024

SELL
$69.43 - $83.43 $47,281 - $56,815
-681 Reduced 58.06%
492 $40,000
Q3 2023

Oct 17, 2023

BUY
$78.22 - $90.4 $5,318 - $6,147
68 Added 6.15%
1,173 $91,000
Q2 2023

Jul 21, 2023

SELL
$79.47 - $91.38 $20,741 - $23,850
-261 Reduced 19.11%
1,105 $97,000
Q1 2023

Apr 18, 2023

BUY
$76.72 - $87.58 $3,298 - $3,765
43 Added 3.25%
1,366 $110,000
Q4 2022

Jan 17, 2023

SELL
$76.18 - $87.74 $62,848 - $72,385
-825 Reduced 38.41%
1,323 $0
Q3 2022

Oct 13, 2022

BUY
$80.75 - $95.31 $5,975 - $7,052
74 Added 3.57%
2,148 $173,000
Q2 2022

Jul 15, 2022

BUY
$87.4 - $113.09 $262 - $339
3 Added 0.14%
2,074 $186,000
Q1 2022

Apr 26, 2022

BUY
$100.58 - $112.38 $201,461 - $225,097
2,003 Added 2945.59%
2,071 $230,000
Q4 2021

Jan 19, 2022

BUY
$99.53 - $127.75 $1,891 - $2,427
19 Added 38.78%
68 $7,000
Q3 2021

Oct 27, 2021

SELL
$122.75 - $135.17 $12,275 - $13,516
-100 Reduced 67.11%
49 $6,000
Q2 2021

Sep 07, 2021

BUY
$118.19 - $131.5 $354 - $394
3 Added 2.05%
149 $19,000
Q1 2021

Sep 07, 2021

SELL
$111.18 - $119.74 $6,003 - $6,465
-54 Reduced 27.0%
146 $17,000
Q4 2020

Sep 07, 2021

SELL
$100.57 - $117.14 $10,057 - $11,714
-100 Reduced 33.33%
200 $23,000
Q3 2020

Sep 07, 2021

BUY
$90.13 - $108.78 $27,039 - $32,634
300 New
300 $31,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.